From 1 September 2026, the eligibility criteria will be expanded further to include adults aged 65 to 74 years in certain clinical at risk groups as advised by the Joint Committee on Vaccination and Immunisation (JCVI):
- chronic respiratory disease – further details https://www.gov.uk/government/publications/rsv-vaccination-expansion-of-eligibility-to-older-adults-in-certain-clinical-risk-groups
- immunosuppression due to disease or treatment
